RETN and ovarian cancer: Our results on chemoresistance are the first reports in ovarian cancer cells, but complement similar findings by other research teams, such as reported role of resistin in inducing resistance against doxorubicin in breast cancer cells13,14, multiple drug resistance in myeloma15 and 5-fluorouracil resistance in colon cancer cells33.